Comparison of pulse and oral steroid in childhood membranoproliferative glomerulonephritis

Journal of Nephrology

Volumn 20, Issue 2, 2007, Pages 234-245

  Bahat, Elif ^a,c   Akkaya, Bahar Kilicarslan ^b   Akman, Sema ^b   Karpuzoglu, Gulten ^b   Guven, Ayfer Gur ^b  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^b AKDENIZ UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Childhood; Membranoproliferative glomerulonephritis; Prognostic factors; Pulse methylprednisolone; Renal survival; Treatment

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; FLUCONAZOLE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PREDNISOLONE; STEROID;

ADOLESCENT; ARTICLE; CHI SQUARE TEST; CHILD; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DRUG DOSE REDUCTION; DRUG PULSE THERAPY; DRUG WITHDRAWAL; FISHER EXACT TEST; FOLLOW UP; GLUCOSURIA; HISTOPATHOLOGY; HUMAN; HYPERGLYCEMIA; HYPERTENSION; KAPLAN MEIER METHOD; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; LONG TERM CARE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; OSTEOPOROSIS; PROGNOSIS; PROTEINURIA; STUDENT T TEST; SUBCAPSULAR CATARACT; SURVIVAL TIME; TONSILLECTOMY; TONSILLITIS; TREATMENT DURATION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; GLUCOCORTICOIDS; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; METHYLPREDNISOLONE; NEPHROTIC SYNDROME; PROTEINURIA; PULSE THERAPY, DRUG; SERUM ALBUMIN; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 34447536959     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Stratta P, Canavese C, Sandri L, Ciccone G, Santi S, Barolo S, Messuerotti A, Quaglia M, Mazzucco G, Fop F, Segoloni GP, Piccoli G. Incidence of biopsy-proven primary glomerulonephritis in an Italian province. Am J Kidney Dis 1996; 27: 631-9.
2. Simon P, Ramee MP, Autuly V, Laruelle E, Charasse C, Cam G, Ang KS. Epidemiology of primary glomerular diseases in a French region: variations according to period and age. Kidney Int 1993; 46: 1192-8.
3. Bohle A, Wehrmann M, Bogenschutz O, Batz C, Vogl W, Schmitt H, Muller CA, Muller GA. The long term prognosis of the primary glomerulonephritides: a morphological and clinical analysis of 1747 cases. Pathol Res Pract 1992; 188: 908-24.
4. Schmitt H, Bohle A, Reineke T, Mayer-Eichberger D, Vogl W. Long-term prognosis of membranoproliferative glomerulonephritis type I: significance of clinical and morphological parameters: an investigation of 220 cases. Nephron 1990; 55: 242-50.
5. Cameron JS, Turner DR, Heaton J, Williams DG, Ogg CS, Chantler C, Haycock GB, Hicks J. Idiopathic mesangiocapillary glomerulonephritis. Comparison of types I and II in children and adults and long-term prognosis. Am J Med 1983; 74: 175-92.
6. Cansick JC, Lennon R, Cummins CL, Howie A J, McGraw ME, Saleem MA, Tizard EJ, Hulton SA, Milford DV, Taylor CM. Prognosis, treatment and outcome of childhood mesangiocapillary (membranoproliferative) glomerulonephritis. Nephrol Dial Transplant 2004; 19: 2769-77.
7. Somers M, Kertesz S, Rosen S Herrin J, Colvin R, Palacios de Carreta N, Kim M. Non-nephrotic children with membranoproliferative glomerulonephritis: are steroids indicated? Pediatr Nephrol 1995; 9: 140-4.
8. Schwertz R, de Jong R, Gretz N Kirschfink M, Anders D, Scharer K. Outcome of idiopathic membranoproliferative glomerulonephritis in children. Acta Paediatr 1996; 85: 308-12.
9. Pedersen RS. Long term prognosis in idiopathic membranoproliferative glomerulonephritis. Scand J Urol Nephrol 1995; 29: 265-72.
10. Mendoza SA, Reznik VM, Griswold W, Krensky A, Yorgin P, Tune B. Treatment of steroid resistant focal segmental glomerulosclerosis with pulse methylprednisolone and alkylating agents. Pediatr Nephrol 1970; 4: 303-7.
11. Arslan S, Saatci U, Ozen S, Bakkaloglu A, Besbas N, Tinaztepe K, Hayran M. Membranoproliferative glomerulonephritis in childhood: factors affecting prognosis. Int Urol Nephrol 1997; 29:711-6.
12. Emre S, Sirin A, Alpay H, Tanman F, Uysal V, Nayir A, Bilge I. Pulse methylprednisolone therapy in children with membranoproliferative glomerulonephritis. Acta Paediatr Jpn 1995; 37: 626-9.
13. Bergstein JM, Andreoli SP. Response of type I membranoproliferative glomerulonephritis to pulse methylprednisolone and alternate-day prednisone therapy. Pediatr Nephrol 1995; 9: 268-71.
14. Faedda R, Satta A, Tanda F, Pirisi M, Bartoli E. Immunosuppressive treatment of membranoproliferative glomerulonephritis. Nephron 1994; 67: 59-65.
15. McEnery PT. Membranoproliferative glomerulonephritis: the Cincinnati experience - cumulative renal survival from 1957 to 1989. J Pediatr 1990; 116: 109-14.
16. International Study of Kidney Diseases in Children. Alternate day steroid treatment in membranoproliferative glomerulonephritis: a randomized controlled clinical trial. Kidney Int 1982; 21: 150.
17. Tarshish P, Bernstein J, Tobin JN, Edelmann CM. Treatment of mesangiocapillary glomerulonephritis with alternate-day prednisolone: a report of the International Study of Kidney Disease in Children. Pediatr Nephrol 1992; 6: 123-30.
18. Ponticelli C, Fogazzi G. Methylprednisolone pulse therapy for primary glomerulonephritis. Am J Nephrol 1989; 9: 41-6.
19. Warady BA, Guggenheim S, Sedman A, Lum GM. Prednisone therapy of membranoproliferative glomerulonephritis in children. J Pediatr 1985; 107: 702-7.
20. Ford DM, Briscoe DM, Shanley PF, Lum GM. Childhood membranoproliferative glomerulonephritis type 1: limited steroid therapy. Kidney Int 1992; 41: 1606-12.